[Treatment of acute lymphoblastic leukemia in adults as an unsolved problem]

MeSH terms

• Adolescent
• Adult
• Age Factors
• Antimetabolites, Antineoplastic / administration & dosage
• Antimetabolites, Antineoplastic / therapeutic use
• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / therapeutic use
• Antineoplastic Agents, Alkylating / administration & dosage
• Antineoplastic Agents, Alkylating / therapeutic use
• Antineoplastic Agents, Hormonal / administration & dosage
• Antineoplastic Agents, Hormonal / therapeutic use
• Antineoplastic Agents, Phytogenic / administration & dosage
• Antineoplastic Agents, Phytogenic / therapeutic use
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Asparaginase / administration & dosage
• Asparaginase / therapeutic use
• Cyclophosphamide / administration & dosage
• Cyclophosphamide / therapeutic use
• Cytarabine / administration & dosage
• Cytarabine / therapeutic use
• Dexamethasone / administration & dosage
• Dexamethasone / therapeutic use
• Humans
• Mercaptopurine / administration & dosage
• Mercaptopurine / therapeutic use
• Methotrexate / administration & dosage
• Methotrexate / therapeutic use
• Middle Aged
• Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications
• Precursor Cell Lymphoblastic Leukemia-Lymphoma / diagnosis
• Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
• Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality
• Remission Induction
• Risk Factors
• Time Factors
• Vincristine / administration & dosage
• Vincristine / therapeutic use